ArticleNeuro-oncology2016

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.

Ka-Loh Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.